Neutrolis
Cambridge, United States· Est.
Neutrolis aims to transform patients' lives and revolutionize the treatment of autoimmune and inflammatory diseases by creating precision therapies to target NETs.
Private Company
Total funding raised: $10M
About
Neutrolis aims to transform patients' lives and revolutionize the treatment of autoimmune and inflammatory diseases by creating precision therapies to target NETs.
Small Molecules
Funding History
1Total raised:$10M
Seed$10M